Cite
HARVARD Citation
Otsuki, Y. et al. (2020). Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT‐targeted therapy. Cancer science. 111 (1), pp. 127-136. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Otsuki, Y. et al. (2020). Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT‐targeted therapy. Cancer science. 111 (1), pp. 127-136. [Online].